These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10371966)

  • 21. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
    Hackmon R; Koifman A; Hyodo H; Glickman H; Sheiner E; Geraghty DE
    Am J Obstet Gynecol; 2007 Sep; 197(3):255.e1-5. PubMed ID: 17826409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy.
    Yie SM; Taylor RN; Librach C
    Am J Obstet Gynecol; 2005 Jul; 193(1):204-8. PubMed ID: 16021080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomenclature and Serology of HLA Class I and Class II Alleles.
    McCluskey J; Kanaan C; Diviney M
    Curr Protoc Immunol; 2017 Aug; 118():A.1S.1-A.1S.6. PubMed ID: 28762487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: does it have a prognostic value?
    Park Y; Kim SJ; Lee SJ; Kim BS
    Leuk Lymphoma; 2008 Aug; 49(8):1623-6. PubMed ID: 18608865
    [No Abstract]   [Full Text] [Related]  

  • 25. Soluble HLA-G changes in maternal blood serum during the progression of labor.
    Knafel A; Basta P; Pitynski K; Mach P; Bednarek W; Klimek M; Zietek J; Zajac K; Dancewicz L; Iwaniec M; Basta A; Wicherek L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):67-73. PubMed ID: 19300382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions.
    Kanangat S; Seder CW; Pergande MR; Lobato GC; Fhied CL; Raouf MF; Liptay MJ; Borgia JA
    Hum Immunol; 2018 Jul; 79(7):558-563. PubMed ID: 29656111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble HLA antigens: new roles and uses.
    Puppo F; Indiveri F; Scudeletti M; Ferrone S
    Immunol Today; 1997 Apr; 18(4):154-5. PubMed ID: 9136450
    [No Abstract]   [Full Text] [Related]  

  • 28. Significant effect of HLA-DRB1 typing by linkage disequilibrium on kidney graft outcome.
    Ichikawa Y; Hashimoto M; Nojima M; Sata M; Fujimoto N; Kyo M; Ishibashi M; Ohshima S; Amemiya H; Fukunishi T
    Transplant Proc; 1993 Aug; 25(4):2707-9. PubMed ID: 8356724
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
    Poehlau D; Kiltz U; Rieks M; Hoffmann V; Rebmann V; Schimrigk S; Grosse-Wilde H; Przuntek H
    Vox Sang; 2000; 78(2):119-21. PubMed ID: 10765148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of the soluble isoforms of HLA-G.
    Hunt JS; Pace JL; Morales PJ; Ober C
    Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble HLA-G: Are they clinically relevant?
    Pistoia V; Morandi F; Wang X; Ferrone S
    Semin Cancer Biol; 2007 Dec; 17(6):469-79. PubMed ID: 17825579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional status of HLA-G at the maternal-fetal interface in recurrent spontaneous abortion.
    Abbas A; Javed S; Agrawal S
    Int J Gynaecol Obstet; 2006 May; 93(2):148-9. PubMed ID: 16546186
    [No Abstract]   [Full Text] [Related]  

  • 33. Soluble HLA-G in rheumatoid arthritis.
    Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
    Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot.
    Matalliotakis IM; Athanassakis I; Goumenou AG; Neonaki MA; Koumantakis EE; Vassiliadis S; Koumantakis EE
    Mediators Inflamm; 2001 Apr; 10(2):75-80. PubMed ID: 11405553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-G: a human pregnancy-related immunomodulator.
    Hunt JS; Langat DL
    Curr Opin Pharmacol; 2009 Aug; 9(4):462-9. PubMed ID: 19570712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-G in murine peripheral blood after interruption of pregnancy.
    Dendrinos S; Kalabalikis G; Makrakis E; Papasteriades C; Creatsas G; Katsorchis T
    Cell Biol Int; 2005 Jun; 29(6):402-7. PubMed ID: 16040259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble human leukocyte antigen-G in pediatric renal transplantation.
    Zarkhin V; Bezchinsky M; Li L; Sarwal MM
    Transplantation; 2011 Jul; 92(1):e1-2. PubMed ID: 21691191
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA-G levels in serum and plasma.
    Rudstein-Svetlicky N; Loewenthal R; Horejsi V; Gazit E
    Tissue Antigens; 2007 Apr; 69 Suppl 1():140-2. PubMed ID: 17445189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HLA-G alleles and risk of early pregnancy loss].
    Sipak-Szmigiel O; Cybulski C; Ronin-Walknowska E; Lubiński J
    Ann Acad Med Stetin; 2008; 54(1):60-4. PubMed ID: 19127811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.
    Alegre E; Díaz-Lagares A; Lemaoult J; López-Moratalla N; Carosella ED; González A
    Hum Immunol; 2007 Aug; 68(8):661-7. PubMed ID: 17678720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.